Journal
ONCOGENE
Volume 32, Issue 16, Pages 2058-2068Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2012.223
Keywords
radiation therapy; radioresistance; tumor microenvironments; hypoxia; hypoxia-inducible factor 1 (HIF-1)
Funding
- Funding Program for NEXT Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS), Japan [LS071]
- Program for Promotion of Fundamental Studies in Health Science from the National Institute of Biomedical Innovation (NIBIO), Japan [09-25]
- Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21791184, 22791190]
- Sagawa Foundation for the Promotion of Cancer Research
- International Science and Technology Cooperation Project of China and Japan [2010DFA31900]
- Grants-in-Aid for Scientific Research [24592336, 22791190, 21791184, 24791293, 22390298, 24659695] Funding Source: KAKEN
Ask authors/readers for more resources
Cancer patients often suffer from local tumor recurrence after radiation therapy. Some intracellular and extracellular factors, such as activity of hypoxia-inducible factor 1 (HIF-1), cell cycle status and oxygen availability, have been suggested to affect DNA damage responses and eventual radioresistant characteristics of cancer cells. But when, where, and how these factors affect one another and induce cellular radioresistance is largely unknown. Here, we analyzed mechanistic and spatio-temporal relationships among them in highly heterogeneous tumor microenvironments. Experiments in vitro demonstrated that a decrease in the glucose concentration reduced the transcriptional activity of HIF-1 and expression of a downstream gene for the cell cycle regulator p27(Kip1) even under hypoxic conditions. Then, the proportion of cells in the radioresistant S phase increased, whereas that radiosensitive G(1) phase decreased, significantly. Immunohistochemical analyses showed that cancer cells in perinecrotic hypoxic regions, which should be under low-glucose conditions, expressed little HIF-1 alpha, and therefore, were mainly in S phase and less damaged by radiation treatment. Continuous administration of glucagon, which increases the blood glucose concentration and so improves glucose availability in perinecrotic hypoxic regions, induced HIF-1 alpha expression and increased radiation-induced DNA damage. Taken all together, these results indicate that cancer cells in perinecrotic regions, which would be under low-glucose and hypoxic conditions, obtain radioresistance by decreasing the level of both HIF-1 activity and p27(Kip1) expression, and adjusting their cell cycle to the radioresistant S phase. Oncogene (2013) 32, 2058-2068; doi:10.1038/onc.2012.223; published online 18 June 2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available